Brasch R C, Caldwell J L
Invest Radiol. 1976;11(5):347-56. doi: 10.1097/00004424-197609000-00002.
An allergic, immunologic mechanism for certain adverse reactions to radiocontrast agents has been postulated on the basis of clinical and theoretical considerations. One obstacle to the acceptance of this allergic theory has been the inability to demonstrate significant antibodies with specificity for these agents. In our studies, rabbits were immunized with 4 analogues of radiocontrast agents which induced IgG or IgE antibodies specific for the contrast media analogues. Then, to determine if antibodies to contrast agents were present in man a prospective, one-year surveillance of radiocontrast agent reactions was undertaken. Sera from 27 patients suffering severe reactions and 37 control subjects were analyzed by radioimmunoassay for antibodies reactive with radiocontrast media. Binding of radiolabeled contrast media was significantly elevated (p less than 0.01) by the serum globulin fraction of the patients suffering severe reactions. Demonstration of this antibody activity, although not proof of cause and effect between the presence of antibody activity and clinical symptoms, nonetheless adds support to the hypothesis that some adverse reactions to radiocontrast agents are due to antibodies.
基于临床和理论上的考虑,有人提出某些针对放射造影剂的不良反应存在过敏、免疫机制。接受这种过敏理论的一个障碍是无法证明存在对这些造影剂具有特异性的显著抗体。在我们的研究中,用4种放射造影剂类似物对兔子进行免疫,这些类似物可诱导出对造影剂类似物具有特异性的IgG或IgE抗体。然后,为了确定人体中是否存在针对造影剂的抗体,我们对放射造影剂反应进行了为期一年的前瞻性监测。通过放射免疫分析对27名发生严重反应的患者和37名对照受试者的血清进行分析,以检测与放射造影剂反应的抗体。发生严重反应患者的血清球蛋白部分使放射性标记造影剂的结合显著升高(p小于0.01)。这种抗体活性的证明,虽然不能证明抗体活性的存在与临床症状之间存在因果关系,但仍然为某些放射造影剂不良反应是由抗体引起的这一假设提供了支持。